Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy Gerona

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
ACS Chemical Neuroscience|November 30, 2020
Synthesis and <i>in Vitro</i> Cannabinoid Receptor 1 Activity of Recently Detected Synthetic Cannabinoids 4F-MDMB-BICA, 5F-MPP-PICA, MMB-4en-PICA, CUMYL-CBMICA, ADB-BINACA, APP-BINACA, 4F-MDMB-BINACA, MDMB-4en-PINACA, A-CHMINACA, 5F-AB-P7AICA, 5F-MDMB-P7AICA, and 5F-AP7AICAAnnelies Cannaert, Eric Sparkes, Edward Pike, et al.
Journal of Occupational and Environmental Hygiene|April 15, 2026
Occupational exposures to illicit drugs in forensic science divisionsJennie Cox, Jacob Bartels, Mamadou Niang, et al.
Chemosphere|February 6, 2023
Reduction of daily-use parabens and phthalates reverses accumulation of cancer-associated phenotypes within disease-free breast tissue of study subjectsShanaz H Dairkee, Dan H Moore, M Gloria Luciani, et al.
Reproductive Toxicology (Elmsford, N.Y.)|December 3, 2020
A pilot investigation of couple-level phthalates exposure and in vitro fertilization (IVF) outcomesThoin F Begum, Victor Y Fujimoto, Roy Gerona, et al.
BMC Infectious Diseases|January 23, 2021
Diagnostic accuracy of a liquid chromatography-tandem mass spectrometry assay in small hair samples for rifampin-resistant tuberculosis drug concentrations in a routine care settingJohn Metcalfe, Peter Bacchetti, Ali Esmail, et al.
Breast Cancer Research and Treatment|February 2, 2012
Estimation of tamoxifen metabolite concentrations in the blood of breast cancer patients through CYP2D6 genotype activity scoreAlan H B Wu, Wendy Lorizio, Simone Tchu, et al.
Drug Testing and Analysis|March 31, 2021
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB<sub>1</sub> receptor activation assays: Part I-Synthesis, analytical characterization, and binding affinity for human CB<sub>1</sub> receptorsEdward Pike, Katharina Elisabeth Grafinger, Annelies Cannaert, et al.
MMWR. Morbidity and Mortality Weekly Report|October 14, 2016
Increase in Adverse Reactions Associated with Use of Synthetic Cannabinoids - Anchorage, Alaska, 2015-2016Yuri P Springer, Roy Gerona, Erich Scheunemann, et al.
Clinical Pharmacokinetics|March 3, 2023
Alternative Methods for Therapeutic Drug Monitoring and Dose Adjustment of Tuberculosis Treatment in Clinical Settings: A Systematic ReviewPrakruti S Rao, Nisha Modi, Nam-Tien Tran Nguyen, et al.
Open Forum Infectious Diseases|November 2, 2022
Agreement Between Measures of Adherence to Isoniazid Preventive Therapy Among People With HIV in UgandaLeah S Forman, Sara Lodi, Robin Fatch, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
ACS Chemical Neuroscience|November 30, 2020
Synthesis and <i>in Vitro</i> Cannabinoid Receptor 1 Activity of Recently Detected Synthetic Cannabinoids 4F-MDMB-BICA, 5F-MPP-PICA, MMB-4en-PICA, CUMYL-CBMICA, ADB-BINACA, APP-BINACA, 4F-MDMB-BINACA, MDMB-4en-PINACA, A-CHMINACA, 5F-AB-P7AICA, 5F-MDMB-P7AICA, and 5F-AP7AICAAnnelies Cannaert, Eric Sparkes, Edward Pike, et al.
Journal of Occupational and Environmental Hygiene|April 15, 2026
Occupational exposures to illicit drugs in forensic science divisionsJennie Cox, Jacob Bartels, Mamadou Niang, et al.
Chemosphere|February 6, 2023
Reduction of daily-use parabens and phthalates reverses accumulation of cancer-associated phenotypes within disease-free breast tissue of study subjectsShanaz H Dairkee, Dan H Moore, M Gloria Luciani, et al.
Reproductive Toxicology (Elmsford, N.Y.)|December 3, 2020
A pilot investigation of couple-level phthalates exposure and in vitro fertilization (IVF) outcomesThoin F Begum, Victor Y Fujimoto, Roy Gerona, et al.
BMC Infectious Diseases|January 23, 2021
Diagnostic accuracy of a liquid chromatography-tandem mass spectrometry assay in small hair samples for rifampin-resistant tuberculosis drug concentrations in a routine care settingJohn Metcalfe, Peter Bacchetti, Ali Esmail, et al.
Breast Cancer Research and Treatment|February 2, 2012
Estimation of tamoxifen metabolite concentrations in the blood of breast cancer patients through CYP2D6 genotype activity scoreAlan H B Wu, Wendy Lorizio, Simone Tchu, et al.
Drug Testing and Analysis|March 31, 2021
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB<sub>1</sub> receptor activation assays: Part I-Synthesis, analytical characterization, and binding affinity for human CB<sub>1</sub> receptorsEdward Pike, Katharina Elisabeth Grafinger, Annelies Cannaert, et al.
MMWR. Morbidity and Mortality Weekly Report|October 14, 2016
Increase in Adverse Reactions Associated with Use of Synthetic Cannabinoids - Anchorage, Alaska, 2015-2016Yuri P Springer, Roy Gerona, Erich Scheunemann, et al.
Clinical Pharmacokinetics|March 3, 2023
Alternative Methods for Therapeutic Drug Monitoring and Dose Adjustment of Tuberculosis Treatment in Clinical Settings: A Systematic ReviewPrakruti S Rao, Nisha Modi, Nam-Tien Tran Nguyen, et al.
Open Forum Infectious Diseases|November 2, 2022
Agreement Between Measures of Adherence to Isoniazid Preventive Therapy Among People With HIV in UgandaLeah S Forman, Sara Lodi, Robin Fatch, et al.
Pageof 6